Nature's Miracle Holding, Inc. Announces Up to $29.7 Million Financing

Nature's Miracle Holding, Inc. Announces Up to $29.7 Million Financing

ONTARIO, Calif., Jan. 13, 2025 /PRNewswire/ -- Nature's Miracle Holding, Inc. (Nasdaq: NMHI) ("Nature's Miracle"), a growing agriculture technology company providing equipment and services to growers, announced that it entered into a Securities...

CBC Group's R-Bridge Announces US$40M Synthetic Royalty-Backed Financing for Mirxes to Advance Global Expansion

CBC Group's R-Bridge Announces US$40M Synthetic Royalty-Backed Financing for Mirxes to Advance Global Expansion

- R-Bridge will provide bespoke financing of US$40 million with a synthetic royalty structure and flexible repayment terms - Financing will accelerate Mirxes, Singapore-based miRNA tech company's innovation and commercialization of cancer early...

Scintimun® Commercialization Partnership with Curium Pharma

Scintimun® Commercialization Partnership with Curium Pharma

MELBOURNE, Australia and LIÈGE, Belgium, Jan. 13, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces that it has entered into an agreement with Curium Pharma for the transfer of marketing...

HARD ROCK HOTEL PENANG MARKS 10 YEARS OF COMMUNITY SPIRIT WITH ROCK TO ROCK RUN 2025

HARD ROCK HOTEL PENANG MARKS 10 YEARS OF COMMUNITY SPIRIT WITH ROCK TO ROCK RUN 2025

GEORGE TOWN, Malaysia, Jan. 13, 2025 /PRNewswire/ -- Hard Rock Hotel Penang proudly announces the return of its highly anticipated charity event, Rock to Rock Run, scheduled for 15 June 2025 at 6.00 am. Press Conference of Rock to Rock Run 2025 at...

Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform

Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform

MELBOURNE, Australia and INDIANAPOLIS, Jan. 13, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces it has entered into an asset purchase agreement with antibody engineering company...

iM Global Partner mourns the passing of Philippe Uzan

iM Global Partner mourns the passing of Philippe Uzan

PARIS, Jan. 13, 2025 /PRNewswire/ -- It is with deep sadness that iM Global Partner (iMGP) announces the passing, one month ago, of our dear friend and colleague, Philippe Uzan. iM Global Partner mourns the passing of Philippe Uzan Philippe's...

Dunxin Financial Holdings Limited Announces Name Change to Eason Technology Limited

Dunxin Financial Holdings Limited Announces Name Change to Eason Technology Limited

HONG KONG, Jan. 11, 2025 /PRNewswire/ -- Dunxin Financial Holdings ("DXF" or the "Company") (OTC Pink: DXFFY, DXFFD) is pleased to announce that effective on January 10, 2025, the Company will change its name to "Eason Technology Limited" and its...

Harbour BioMed Announces License Agreement with Windward Bio for HBM9378/SKB378, an Anti-TSLP Fully Human Antibody for Immunological Diseases

Harbour BioMed Announces License Agreement with Windward Bio for HBM9378/SKB378, an Anti-TSLP Fully Human Antibody for Immunological Diseases

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Jan. 10, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody...

Psylo Rebrands as Xylo, with Key Board Appointments and Breakthrough Pipeline Progress

Psylo Rebrands as Xylo, with Key Board Appointments and Breakthrough Pipeline Progress

Announces Major Milestones at the JPM Healthcare Conference SAN FRANCISCO, Jan. 10, 2025 /PRNewswire/ -- Psylo, a leader in neurotherapeutics discovery and development, has officially rebranded as Xylo Bio. This transformation reflects the company's...

Argon Medical Announces First Patient Enrollment in CLEAN-PE, a Prospective, Multicenter Study of a New Treatment for Pulmonary Embolism

Argon Medical Announces First Patient Enrollment in CLEAN-PE, a Prospective, Multicenter Study of a New Treatment for Pulmonary Embolism

PLANO, Texas, Jan. 9, 2025 /PRNewswire/ -- Argon Medical Devices, a leading provider of device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology procedures, announced the first patient enrollment in...

  • 1
  • ...
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • ...
  • 130
  • menu
    menu